Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM

Dr Paul Richardson speaks to ecancer about the updated data from the results of a phase 3 DETERMINATION trial using lenalidomide, bortezomib, and dexamethasone (RVd) plus or minus autologous stem cell transplantation (ASCT) and retuximab maintenance to progression for newly diagnosed multiple myeloma (NDMM).

Видео EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM канала ecancer
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
23 июня 2022 г. 21:23:44
00:02:19
ecancer
Правообладателям
Жалоба
Комментарии
Другие видео канала
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLCAmivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLCAn AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...Identifying causing mechanisms in cancers with unknown primary site improves treatment & survivalIdentifying causing mechanisms in cancers with unknown primary site improves treatment & survivalRegional lymph node irradiation in early breast cancerRegional lymph node irradiation in early breast cancerDr. Aizik Wolf -- Cuantas metástasis tratarDr. Aizik Wolf -- Cuantas metástasis tratarHalving duration of ADT for high risk prostate cancer patientsHalving duration of ADT for high risk prostate cancer patientsLatest advances in mHSPC from ASCO GU 2020Latest advances in mHSPC from ASCO GU 2020ESMO 2017: Prostate cancer highlightsESMO 2017: Prostate cancer highlightsTargeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humansTargeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humansBreast cancer highlights from ASCO 2019Breast cancer highlights from ASCO 2019Causes, symptoms, and prevention of skin cancerCauses, symptoms, and prevention of skin cancerDurvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...The CAR T cell revolution in cancer therapyThe CAR T cell revolution in cancer therapyPhase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patientsPhase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patientsCLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLLCLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLLCLL14: Venetoclax plus obinutuzumab in untreated CLLCLL14: Venetoclax plus obinutuzumab in untreated CLLProstate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...Managing the side effects of CAR T-cell therapyManaging the side effects of CAR T-cell therapyLUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RTLUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RTMaintenance chemotherapy extends life for children with rare rhabdomyosarcomaMaintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала